BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1186122)

  • 21. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides.
    Williams PD; Hottendorf GH; Bennett DB
    J Pharmacol Exp Ther; 1986 Jun; 237(3):919-25. PubMed ID: 3754895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental gentamicin nephrotoxicity: effect of streptozotocin-induced diabetes.
    Elliott WC; Houghton DC; Gilbert DN; Baines-Hunter J; Bennett WM
    J Pharmacol Exp Ther; 1985 Apr; 233(1):264-70. PubMed ID: 3156984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of gentamicin-induced nephrotoxicity by lithium in rat.
    Samadian T; Dehpour AR; Amini S; Nouhnejad P
    Histol Histopathol; 1993 Jan; 8(1):139-47. PubMed ID: 8443425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5'-phosphate in the rat.
    Kacew S
    J Pharmacol Exp Ther; 1989 Jan; 248(1):360-6. PubMed ID: 2492342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of the acute effect of gentamicin on the renal handling of electrolytes in the rat.
    Foster JE; Harpur ES; Garland HO
    J Pharmacol Exp Ther; 1992 Apr; 261(1):38-43. PubMed ID: 1560382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of hepatic microsomal structure and function by indium chloride. Ultrastructural, morphometric, and biochemical studies.
    Fowler BA; Kardish RM; Woods JS
    Lab Invest; 1983 Apr; 48(4):471-8. PubMed ID: 6834787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of renal medullary lysosomes during potassium depletion nephropathy.
    Aithal HN; Toback FG; Dube S; Getz GS; Spargo BH
    Lab Invest; 1977 Feb; 36(2):107-13. PubMed ID: 839728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly-D-glutamic acid induces an acute lysosomal thesaurismosis of proximal tubules and a marked proliferation of interstitium in rat kidney.
    Kishore BK; Maldague P; Tulkens PM; Courtoy PJ
    Lab Invest; 1996 Jun; 74(6):1013-23. PubMed ID: 8667606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
    Yamada T
    Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regenerating tubular cell process in rat kidney: influence of gentamicin treatment.
    Olier B; Morin JP; Grancher G; Fillastre JP
    Int J Tissue React; 1987; 9(3):241-50. PubMed ID: 3596965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of renal membrane binding and nephrotoxicity of gentamicin by polyasparagine and polyaspartic acid in the rat.
    Williams PD; Hottendorf GH
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):317-20. PubMed ID: 3838817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of aminoglycoside nephrotoxicity by vitamin-D-induced hypercalcemia.
    Cohen R; Johnson K; Humes HD
    Miner Electrolyte Metab; 1988; 14(2-3):121-8. PubMed ID: 3380067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time dependent effects of gentamicin on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in rat kidney tissues.
    Banday AA; Farooq N; Priyamvada S; Yusufi AN; Khan F
    Life Sci; 2008 Feb; 82(9-10):450-9. PubMed ID: 18201728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Behavior of gentamicin in the kidney parenchyma. Studies on rats during and after treatment with therapeutic doses].
    Chauvin JM; Rudhardt M; Blanchard P; Gaillard R; Fabre J
    Schweiz Med Wochenschr; 1978 Jul; 108(27):1020-5. PubMed ID: 663595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gentamicin nephrotoxicity. II. Physiological, biochemical and morphological effects of prolonged administration to rats.
    Cuppage FE; Setter K; Sullivan P; Reitzes EJ; Melnykovych AO
    Virchows Arch B Cell Pathol; 1977 Jun; 24(2):121-38. PubMed ID: 407707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in renal cortical phospholipid content induced by gentamicin: time course, specificity, and subcellular localization.
    Knauss TC; Weinberg JM; Humes HD
    Am J Physiol; 1983 May; 244(5):F535-46. PubMed ID: 6846542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
    Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical effects of gentamicin on rat kidney cortex. II. Analytical subfractionation after short-term, high-dose treatment.
    Nässberger L; Bergstrand A; DePierre JW
    Exp Mol Pathol; 1987 Apr; 46(2):230-43. PubMed ID: 3030800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gentamicin induces a lysosomal phospholipidosis in cultured rat fibroblast [proceedings].
    Goffeau A; Aubert-Tulkens G; Van Hoff F
    Arch Int Physiol Biochim; 1978 May; 86(2):403-5. PubMed ID: 80995
    [No Abstract]   [Full Text] [Related]  

  • 40. Intracellular distribution of gentamicin within the rat kidney cortex: a cell fractionation study.
    Nässberger L; Bergstrand A; DePierre JW
    Exp Mol Pathol; 1990 Apr; 52(2):212-20. PubMed ID: 2332038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.